Cargando…
GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression
GPR55 recognizes several lipid molecules such as lysophosphatidylinositol. GPR55 expression was reported in human monocytes. However, its role in monocyte adhesion and atherosclerosis development has not been studied. The role of GPR55 in monocyte adhesion and atherosclerosis development was investi...
Autores principales: | Lee, Seung-Jin, Im, Dong-Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658038/ https://www.ncbi.nlm.nih.gov/pubmed/34884889 http://dx.doi.org/10.3390/ijms222313084 |
Ejemplares similares
-
CID16020046, a GPR55 antagonist, attenuates sepsis-induced acute kidney injury
por: Chen, Rongxin, et al.
Publicado: (2022) -
GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
por: Im, Dong-Soon
Publicado: (2021) -
SIRT1 inhibits monocyte adhesion to the vascular endothelium by suppressing Mac-1 expression on monocytes
por: Lee, Seung Jin, et al.
Publicado: (2019) -
Thienopyrimidine
Derivatives as GPR55 Receptor Antagonists:
Insight into Structure–Activity Relationship
por: Figuerola-Asencio, Laura, et al.
Publicado: (2022) -
Ginseng Gintonin Contains Ligands for GPR40 and GPR55
por: Cho, Yeon-Jin, et al.
Publicado: (2020)